Empowered Funds’s Edwards Lifesciences EW Stock Holding History

Empowered Funds’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.57M	Buy	+82,019	New	+$6.76M	0.04%	535
2025 Q4	–	Sell	-16,764	Closed	-$1.3M	–	1277
2025 Q3	$1.3M	Sell	16,764 -21,208	-56%	-$1.66M	0.01%	1093
2025 Q2	$2.97M	Buy	37,972 +26,596	+234%	+$1.98M	0.03%	641
2025 Q1	$825K	Sell	11,376 -14,157	-55%	-$1.01M	0.01%	1061
2024 Q4	$1.89M	Buy	25,533 +1,501	+6%	+$105K	0.03%	757
2024 Q3	$1.59M	Buy	24,032 +2,324	+11%	+$169K	0.02%	751
2024 Q2	$2.01M	Buy	21,708 +1,585	+8%	+$140K	0.03%	610
2024 Q1	$1.92M	Buy	20,123 +12,112	+151%	+$1.02M	0.03%	639
2023 Q4	$611K	Buy	8,011 +2,813	+54%	+$196K	0.02%	945
2023 Q3	$360K	Buy	5,198 +963	+23%	+$77.4K	0.01%	1017
2023 Q2	$399K	Buy	4,235 +1,570	+59%	+$136K	0.01%	886
2023 Q1	$220K	Buy	+2,665	New	+$209K	0.01%	490

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Empowered Funds's EW Position: Q1 2026 in Review

Empowered Funds opened a new position in Edwards Lifesciences (EW) in Q1 2026: 82,019 shares worth $6.57M. The stake represents 0.04% of the portfolio and ranks #535 among its holdings. This is a return to the name: Empowered Funds previously reported a position in EW as recently as Q3 2025.

Empowered Funds first reported a position in EW in Q1 2023 and has held it in 12 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Empowered Funds held 82,019 shares of Edwards Lifesciences worth $6.57M as of Q1 2026.
Edwards Lifesciences was a new Empowered Funds position in Q1 2026.
Edwards Lifesciences made up 0.04% of Empowered Funds's portfolio in Q1 2026, its #535 holding.
Empowered Funds first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 12 quarters since.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.